GCPRs Targeted Drug Discovery Summit Hilton Boston Back Bay, Boston

GPCRs-targeted drug discovery continues to gain exponential momentum, with advances in screening tools, characterization of dynamic confirmations and basic GPCR biology, including orphan receptors. Coupled with numerous strategic collaboration and investment, the GPCR field is fuelling for the clinical progression of next-generation small molecules and biologics across a spectrum of indications and previously undrugged GPCR targets.

Owing to this, the Annual GPCRs-Targeted Drug Discovery Summit returns for its 3rd year as the world’s only and most comprehensive industry dedicated GPCR forum. Bringing two brand new specialized tracks of content (Target ID and Validation and Hit ID and Optimization), don’t miss out on your ultimate chance to unite with 100+ GPCR experts devoted to accelerating the discovery of new, transformative small molecules and biologics.

Speakers: Adnan Sljoka Principal Investigator RIKEN Center for Integrative Medical Sciences, Ajay Yekkirala Co-Founder, Senior Vice President and Head of Discovery Superluminal Medicines Inc, Andreas Busch Senior Scientist – Protein Science Confo Therapeutics, Aurélien Rizk Co-Founder and Chief scientific officer InterAx Biotech, Barbara Cipriani Vice President and Head of Biology Pathios Therapeutics and more.

⌛ Event Dates & Venue

05 Mar - 07 Mar 2024, 8:00 am - 5:00 pm

💸 Website & Tickets

Go to Event Website
Ticket Pricing:
Drug Developer Pricing - Conference + Focus Day: USD 4297.00, Drug Developer Pricing - Conference Only: USD 2999.00, Discounted Pricing - Conference + Focus Day: USD 3697.00, Discounted Pricing - Conference Only: USD 2599.00, Vendor Pricing - Conference + Focus Day: USD 5197.00, Vendor Pricing - Conference Only: USD 3699.00

◑ Topics | Categories